In this episode we explore the innate immune system and find out what it is, what it does and why it matters in both health and disease. You'll hear various perspectives from both academic and industry experts who are active in research in this field, including Dr Glen Barber (Miami), Prof George Coukos (Lausanne), Dr Adi Diab (MD Anderson), Dr Tom Dubensky (Tempest Therapeutics via Aduro Biotech), Dr Tom Gajewski (Chicago), Dr Jonathan Lancaster (Myriad), Dr Ira Mellman (Genentech), Prof Eric Vivier (Innate Pharma via Marseille Immunopole/CIML), Dr Jonathan Zalevsky (Nektar Therapeutics). Some important topics we will cover: - What is the innate immune system? - What does it do? - How is it different from the adaptive immune system? - Is it really separate from the adaptive system? - STING (Stimulator of Interferon Genes) - Biomarkers - Toll-like Receptors (TLRs) You can find more detailed information about the topics discussed in the show notes on https://noveltargets.com. These interviews were conducted in various cities around the world or at AACR, ASCO and SITC meetings between 2016 to 2018. Full transcripts of the individual interviews can be found on https://biotechstrategyblog.com The music is by violinist and composer David Schulman. Listen to more at http://quietlifemotel.com. © 2018 Blue Ice Publishing LLC. All Rights Reserved